Nelly Mugo, MBChB, MMed, MPH

Research Associate Professor, Global Health

Prof. Nelly R. Mugo is an associate research professor in the Department of Global Health at the University of Washington, a senior principal clinical research scientist at the Kenya Medical Research Institute (KEMRI), and a reproductive health specialist with three decades of work experience. Her research focus has been on the prevention of HIV and cervical cancer among other reproductive health research work.  She has been an investigator on two landmark clinical trials, the Partners PrEP study that contributed evidence to inform the change of indication for use of Truvada as HIV prevention pre-exposure prophylaxis (PrEP) and a protocol lead for the ongoing ‘Kenya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study –’ that has provided evidence on the efficacy of single-dose HPV vaccination. She is a member of the International Papillomavirus Society education committee, and the Kenya Obstetrics and Genecology society and has contributed to several World Health Organization and Kenya ministry of health working group scientific committees. She is widely published in peer review journals.

Publications

  1. Ogello, V, Ngure, K, Mwangi, P, Owidi, E, Wairimu, N, Etyang, L et al.. HIV Self-Testing for Efficient PrEP Delivery Is Highly Acceptable and Feasible in Public Health HIV Clinics in Kenya: A Mixed Methods Study. J Int Assoc Provid AIDS Care. 2024;23 :23259582241274311. doi: 10.1177/23259582241274311. PubMed PMID:39155573 PubMed Central PMC11331458.
  2. Morrison, S, Batting, J, Wanga, V, Beesham, I, Deese, J, Hofmeyr, GJ et al.. True and false positive HIV point of care test results in a prospective multinational study of at-risk African women: implications for large-scale repeat HIV testing in HIV prevention programs. J Acquir Immune Defic Syndr. 2024; :. doi: 10.1097/QAI.0000000000003497. PubMed PMID:39085989 .
  3. Njuguna, N, Akolo, C, Anzala, O, Baeten, JM, Heffron, R, Mugo, NR et al.. Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic. Curr HIV/AIDS Rep. 2024;21 (5):257-263. doi: 10.1007/s11904-024-00703-2. PubMed PMID:39052142 .
  4. MacLean, F, Tsegaye, AT, Graham, JB, Swarts, JL, Vick, SC, Potchen, N et al.. Bacterial vaginosis-driven changes in vaginal T cell phenotypes and their implications for HIV susceptibility. bioRxiv. 2024; :. doi: 10.1101/2024.07.03.601916. PubMed PMID:39005354 PubMed Central PMC11245000.
  5. Gandhi, M, Glidden, DV, Chakravarty, D, Wang, G, Biwott, C, Mogere, P et al.. Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial. Lancet HIV. 2024;11 (8):e522-e530. doi: 10.1016/S2352-3018(24)00125-5. PubMed PMID:38976993 PubMed Central PMC11376217.
Search PubMed

Comments are closed.